Interleukin-2 (IL-2) Treatment for HIV Infected Patients Who Have Interrupted Their Anti-HIV Drug Therapy

NCT00038259 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

21

Enrollment

NIH

Sponsor class

Conditions

HIV Infections

Interventions

DRUG: Aldesleukin

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)